Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02574455 |
|---|---|
| Brief Title: | Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) (ASCENT) |
| First Submitted : | October 8, 2015 |
| First Submitted that Met QC Criteria : | October 9, 2015 |
| First Posted : | October 12, 2015 (Estimate) |
| Results First Submitted : | March 11, 2021 |
| Results First Posted with QC Comments : | April 6, 2021 |
| Results First Submitted that Met QC Criteria : | April 29, 2021 |
| Results First Posted : | April 30, 2021 |
| Last Update Submitted that Met QC Criteria : | May 26, 2022 |
| Last Update Posted : | June 15, 2022 |